Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.06.02.729534

Vertical stratification drives additive prokaryotic diversity in beech forest floors, while site conditions shape boundary layers

Abstract

The forest floor is a key interface regulating carbon and nutrient processing and transfer to the mineral soil, yet it is threatened by climate-change-driven reductions in organic layer mass. How its prokaryotic microbiome is structured across the fine-scale vertical gradient from fresh litter to mineral topsoil remains poorly resolved. We characterised prokaryotic communities across eight sequential layers spanning fresh litter, organic layers at different stages of decomposition, and mineral topsoil in three temperate beech forests using 16S rRNA gene amplicon sequencing. The decomposition stage was the dominant driver of community assembly, resulting in a strongly vertically stratified prokaryotic microbiome. While alpha diversity peaked within the fragmented litter layers, the overall high diversity of the forest floor was primarily an additive effect of vertical stratification. Site-specific effects were pronounced in the litter layer and the mineral topsoil, but diminished in the intermediate organic layers, where high local heterogeneity masked between-site differences. Redundancy analysis further showed that the environmental drivers of community structure shifted with depth, from litter quality in the upper horizons to mineral-associated properties in the mineral topsoil. At the same time, predicted 16S rRNA gene copy numbers indicate that the humified layers harbour the highest abundance of oligotrophic life strategists in the profile. By resolving the fine-scale vertical structure of the forest floor prokaryotic microbiome, our results provide a baseline for predicting how climate-change induced loss of organic layer mass threatens layer-specific communities, particularly the oligotrophic taxa in the humified layers, with consequences for the carbon turnover, tree nutrition, and nutrient cycling functions they mediate.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Bibinger, S., Niederberger, J., Lang, F., Schloter, M., Schulz, S.. 2026-06-03. Vertical stratification drives additive prokaryotic diversity in beech forest floors, while site conditions shape boundary layers. https://doi.org/10.64898/2026.06.02.729534

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

pTRIP, a novel integration plasmid for Listeria monocytogenes

In the past decades, several tools to genetically modify the human pathogen Listeria monocytogenes were developed. Here, we constructed a new integrative plasmid system for L. monocytogenes named pTRIP, for treB insertion plasmid. pTRIP is a vector which stably integrates into the treB locus of the wild type EGD-e. This locus encodes the sole trehalose-specific EIIB and EIIC component of a phosphotransferase system. Successful integration leads to the disruption of treB and thus, to an inability of the resulting L. monocytogenes strains to grow on trehalose as sole carbon source. Due to integration through double homologous recombination, it is the first integrative system which does not require antibiotic selection pressure. To assess functionality of the pTRIP system, prfA and its native promoter region were integrated into the treB locus of a {Delta}prfA strain. Complementation was confirmed in 78% of the isolated clones, indicating successful integration of prfA into the treB locus. We further constructed derivatives of pTRIP harboring the constitutive Pp60 (pTRIP1) and the inducible Prha (pTRIP2) promoter to further expand application possibilities. Microscopic analyses confirmed the functionality of both promoter constructs and showed dose-dependent induction for Prha. pTRIP is an efficient tool for stable gene expression as well as functional studies and expands genetic modification possibilities for L. monocytogenes.

microbiology↗

A rational design strategy and validation for protease-resistant fusion-inhibitor antiviral peptides

Peptide-based fusion inhibitors are promising pharmaceuticals in the fight against enveloped viruses relying on membrane fusion for host infection. However, peptide therapeutic applications have long been hindered by their poor stability in vivo. Here, we discovered that peptide inhibitors with the wildtype sequence of the heptad repeat 2 (HR2) domain of the SARS-CoV-2 spike protein are efficiently cleaved by Transmembrane Protease, Serine 2 (TMPRSS2), a key protease involved in the SARS-CoV-2 virus-cell fusion pathway. We then identified the corresponding cleavage sites and designed three protease-resistant peptides using ranking based on deep mutational scanning and natural occurrence. The three candidates all exhibit inhibitory activity in a cell-cell fusion assay. A high-resolution cryo-EM structure of the top candidate, HR2-NHN, bound to its HR1 target reveals the molecular basis for its potent activity. The top candidate of the cell-based screening assay significantly improved efficacy relative to the wildtype peptide when administered 12 h before infection in both an authentic virus-cell infection assay and a mouse assay. More broadly, our results suggest that the design strategies for protease-resistant peptides could be applied to a broad spectrum of other enveloped viruses and pave the way for the development of safe, prophylactic antivirals that can be administered before exposure.

microbiology↗

Host soluble inositol phosphate signaling promotes coronavirus replication

Coronaviruses rely extensively on host pathways for replication, making host-directed therapies an attractive strategy for broad-spectrum antivirals with reduced risk of viral resistance. Here we identify the host soluble inositol phosphate pathway as a previously unrecognized dependency for coronavirus infection. Genetic or pharmacologic inhibition of several kinases in this pathway markedly suppresses replication of both alpha- and betacoronaviruses, while increasing pathway activity promotes viral replication. We developed UNC7844, a potent multi-target inhibitor of these kinases, which reduces coronavirus replication by more than four orders of magnitude in cultured cells and suppresses coronavirus infection in mice. Mechanistically, UNC7844 suppresses inositol (pyro)phosphates production, disrupts phosphoinositide homeostasis, and impairs late endosomal dynamics, blocking early post-entry steps required for viral genome release and replication. Together, our findings establish the soluble inositol (pyro)phosphate pathway as an important regulator of coronavirus infection and highlight its inhibition as a promising host-directed antiviral strategy.

microbiology↗